VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $535,898 | -61.8% | 57,193 | 0.0% | 0.05% | -52.8% |
| Q2 2023 | $1,402,944 | +5.4% | 57,193 | 0.0% | 0.11% | -4.4% |
| Q1 2023 | $1,330,881 | +91811.7% | 57,193 | 0.0% | 0.11% | -13.1% |
| Q4 2022 | $1,448 | -99.9% | 57,193 | 0.0% | 0.13% | +18.2% |
| Q3 2022 | $1,103,000 | +12.0% | 57,193 | +47.9% | 0.11% | +12.2% |
| Q2 2022 | $985,000 | -44.6% | 38,679 | -9.0% | 0.10% | -30.5% |
| Q1 2022 | $1,779,000 | 0.0% | 42,484 | 0.0% | 0.14% | 0.0% |
| Q4 2021 | $1,779,000 | -4.2% | 42,484 | -0.4% | 0.14% | -15.1% |
| Q3 2021 | $1,857,000 | +6.3% | 42,667 | +15.5% | 0.17% | +5.7% |
| Q2 2021 | $1,747,000 | -3.6% | 36,945 | +4.5% | 0.16% | -11.8% |
| Q1 2021 | $1,813,000 | – | 35,357 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |